The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
GSK’s pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
In two studies with over 3,000 women and children who had a mild UTI, Blujepa, a pill taken twice a day for five days, worked as well as or better than nitrofurantoin, a common UTI antibiotic.